Rijneveld A, van der Holt B, de Weerdt O, et al. Randomized phase III HOVON-100 study of clofarabine combined with standard treatment in adult patients with newly diagnosed ALL. 24th Congress of EHA, abstract PS937.
RUNX1-remmers verhinderen groei primaire T-ALL-cellen
okt 2017 | Leukemie